Chiltern opens new office in Russia

Global research organisation Chiltern has opened a new office in St Petersburg, Russia, following the recent appointment of Dr Alexey V. Kornilov as general manager of its Russian operations.

The office will be primarily focused on supporting Chiltern's Global Clinical Development brand. Over the last few years, Chiltern has conducted many trials in Russia to fulfil sponsors' demands in the region and to take advantage of highly qualified investigator sites generating high quality data.

"Today, the pharmaceutical industry increasingly recognises the potential of CEE countries to meet enrolment goals," said Dr Armand Czaplinski Chiltern general manager, CEE. "The availability of trained staff and the quality of the data produced, has resulted in an increased number of FDA and EMEA approved clinical trials."